Clinical trials: Lipodystrophy Syndrome Related to HIV Infection
- Condition Lipodystrophy Syndrome Related to HIV Infection
- Funder type Industry (pharma, biotech, devices)
HIV Infections
A Study of Amprenavir in Patients With Protease Inhibitor-Related Complications
The purpose of this study is to see if it is safe and effective to give the protease inhibitor (PI) amprenavir (APV) to patients with fat production and distribution problems associated with other PIs.
- Trial name
- NCT00002417
- Testing
- Amprenavir
- Where
- United States
- Sponsor
- Glaxo Wellcome